Andrew Pollack

New York Times

Guest

Correspondent for the New York Times, covering the business and science of biotechnology

Andrew Pollack on KCRW

Mylan might or might not have good news for people who need EpiPens.

Drug-maker Mylan and its $300 "generic" EpiPen

Mylan might or might not have good news for people who need EpiPens.

from To the Point

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

When Drug Prices Skyrocket Overnight

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

from To the Point

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

The Ebola Drug

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

from Press Play with Madeleine Brand

More from KCRW

Ketamine clinics are popping up all over Los Angeles offering to treat depression, anxiety, and other ailments. But are their claims legitimate?

from Greater LA

Bob Hertzberg, one of the three leading candidates seeking to represent the 3rd District of the LA County Board of Supervisors, speaks with KCRW and KPCC/LAist.

Loyola Law School professor Jessica Levinson breaks down the significance of the U.S. Supreme Court opinion draft leak on Roe v. Wade and the intentions behind it.

from Press Play with Madeleine Brand

How long will food prices continue to surge? They’ve been going up due to pandemic-induced supply chain disruptions and the Russia-Ukraine conflict.

from Press Play with Madeleine Brand

Dr. Lucy Jones left behind a gig with the U.S. Geological Survey to devote her energy to fighting climate change. And she’d like to see music play a bigger role in the effort.

from KCRW Features

When it came to the Ukraine conflict, Professor Michael J. Brenner did what he’s done his whole life: question American foreign policy. This time the backlash was vitriolic.

from Scheer Intelligence

Zócalo commentator Joe Mathews is a fierce defender of direct democracy. But he says California’s take on citizen power is making things worse.

from Zócalo's Connecting California

Veteran award-winning journalists Patrick Cockburn and Robert Scheer, who met in Moscow in 1987 when Mikhail Gorbachev optimistically promised peace, now fear a descent into nuclear…

from Scheer Intelligence

Three decades after Rodney King was pulled over for a traffic violation and beaten by the LAPD, law enforcement officers are now learning to reduce pretextual stops.

from KCRW Features